Glycosylation is an integral post-translational modification present in more than half of all eukaryotic proteins. It affects key protein functions, including folding, stability, and immunogenicity. Glycoengineering approaches, such as the use of bacterial N-glycosylation systems, or expression systems, including yeasts, insect cells, and mammalian cells, have enabled access to defined and homogenous glycoproteins. Because glycan structures on proteins can be recognized by host lectin receptors, they may facilitate cell-specific targeting and immune modulation. Myeloid C-type lectin receptors (CLRs) expressed by antigen-presenting cells are attractive targets to shape immune responses. Multivalent glycan display on nanoparticles, liposomes,...
Cancer immunotherapy requires potent tumor-specific CD8+ and CD4+ T-cell responses, initiated by den...
DCs (dendritic cells) are specialized in the recognition of pathogens and play a pivotal role in the...
Cancer immunotherapy requires potent tumor-specific CD8+ and CD4+ T-cell responses, initiated by den...
Glycosylation is an integral post-translational modification present in more than half of all eukary...
Glycosylation is an integral post-translational modification present in more than half of all eukary...
Glycan structures are common posttranslational modifications of proteins, which serve multiple impor...
Glycan structures are common posttranslational modifications of proteins, which serve multiple impor...
C-type lectin receptors (CLRs) are important in several immune regulatory processes. These receptors...
Glycan structures are common posttranslational modifications of proteins, which serve multiple impor...
Glycan structures are common posttranslational modifications of proteins, which serve multiple impor...
Glycan structures are common posttranslational modifications of proteins, which serve multiple impor...
Glycans play a crucial role to discern between self and foreign entities by providing key recognitio...
Targeting antigens to dendritic cell subsets is a promising strategy to enhance the efficacy of vacc...
Glycan structures are common posttranslational modifications of proteins, which serve multiple impor...
Recognition of viral glycans by pattern recognition receptors (PRRs) in innate immunity contributes ...
Cancer immunotherapy requires potent tumor-specific CD8+ and CD4+ T-cell responses, initiated by den...
DCs (dendritic cells) are specialized in the recognition of pathogens and play a pivotal role in the...
Cancer immunotherapy requires potent tumor-specific CD8+ and CD4+ T-cell responses, initiated by den...
Glycosylation is an integral post-translational modification present in more than half of all eukary...
Glycosylation is an integral post-translational modification present in more than half of all eukary...
Glycan structures are common posttranslational modifications of proteins, which serve multiple impor...
Glycan structures are common posttranslational modifications of proteins, which serve multiple impor...
C-type lectin receptors (CLRs) are important in several immune regulatory processes. These receptors...
Glycan structures are common posttranslational modifications of proteins, which serve multiple impor...
Glycan structures are common posttranslational modifications of proteins, which serve multiple impor...
Glycan structures are common posttranslational modifications of proteins, which serve multiple impor...
Glycans play a crucial role to discern between self and foreign entities by providing key recognitio...
Targeting antigens to dendritic cell subsets is a promising strategy to enhance the efficacy of vacc...
Glycan structures are common posttranslational modifications of proteins, which serve multiple impor...
Recognition of viral glycans by pattern recognition receptors (PRRs) in innate immunity contributes ...
Cancer immunotherapy requires potent tumor-specific CD8+ and CD4+ T-cell responses, initiated by den...
DCs (dendritic cells) are specialized in the recognition of pathogens and play a pivotal role in the...
Cancer immunotherapy requires potent tumor-specific CD8+ and CD4+ T-cell responses, initiated by den...